Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers
Authors:
- A. Guimarães-WalkerAGA. Guimarães-Walker
- N. MackieNMN. Mackie
- S. McCormackSMS. McCormack
- T. HankeTHT. Hanke
- C. SchmidtCSC. Schmidt
- J. GilmourJGJ. Gilmour
- B. BarinBBB. Barin
- A. McMichaelAMA. McMichael
- J. WeberJWJ. Weber
- K. LeggKLK. Legg
- A. BabikerABA. Babiker
- P. HayesPHP. Hayes
- 1 December 2008
- Vol. 26 (51) , 6671-6677
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Studies of a prophylactic HIV-1 vaccine candidate based on modified vaccinia virus Ankara (MVA) with and without DNA priming: Effects of dosage and route on safety and immunogenicityVaccine, 2007
- Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell inductionJournal of General Virology, 2007
- Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+T-Cell EpitopesJournal of Virology, 2006
- Expansion and Diversification of Virus-Specific T Cells following Immunization of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals with a Recombinant Modified Vaccinia Virus Ankara/HIV-1 Gag VaccineJournal of Virology, 2006
- HIV VACCINESAnnual Review of Immunology, 2006
- Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteersVaccine, 2006
- A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humansJournal of General Virology, 2004
- Development of a DNA-MVA/HIVA vaccine for KenyaVaccine, 2002
- Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya.Nature Medicine, 2000
- Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDSImmunology Letters, 1999